Thietane-containing 4-(2-oxo-2-phenylethyl)-1H-1,2,4-triazol-4-ium bromides were synthesized by quaternization of thietanyltriazoles with phenacyl bromides. The starting thietanyltriazoles were obtained by the reaction of 1,2,4-triazoles and 2-chloromethylthiirane followed by oxidation of 1-(thietan-3-yl)-1,2,4-triazole to 1-(1-oxidotheitan-3-yl)-1,2,4-triazole and 1-(1,1-dioxidothietan-3-yl)-1,2,4-triazole. The structures of the synthesized compounds were confirmed by IR, PMR, and 13C and 15N NMR spectroscopy. An in vivo study of the antidepressant activity revealed the promising compound 1-(1,1-dioxidothietan-3-yl)-4-(2-oxo-2-phenylethyl)-1H-1,2,4-triazol-4-ium bromide (IXa), which statistically significantly reduced the duration of immobilization in the forced swimming test by 44% as compared to the control group. Compound IXa is a low-toxic substance (class 4 toxicity) with a high bioavailability predicted according to in silico calculations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Notes
Values expressed in percent of the control value taken as 100%.
References
D. F. Santomauro, A. M. Mantilla Herrera, J. Shadid, et al., Lancet, 398, 1700 – 1712 (2021).
M. Sanches, J. Quevedo, and J. C. Soares, Prog. Neuropsychopharmacol. Biol. Psychiatry, 106, 110157 (2021).
Y. Xu, C. Wang, J. J. Klabnik, and J. M. O’ Donnell, Curr. Neuropharmacol., 12, 108-119 (2014).
I. L. Nikitina, R. A. Gabidullin, E. E. Klen, et al., Khim.-farm. Zh., 46(4), 17-22-2012); Pharm. Chem. J., 46(4), 213 – 218-(2012).
E. E. Klen, I. L. Nikitina, N. N. Makarova, et al., Khim.-farm. Zh., 50(10), 15-21-2016); Pharm. Chem. J., 50(10), 642 – 648 (2016).
F. A. Khaliullin, I. L. Nikitina, E. E. Klen, et al., Khim.-farm. Zh., 53, No. 12, 8 – 15-2019); Pharm. Chem. J., 53(12), 1106 – 1112 (2019).
I. L. Nikitina and G. G. Gaisina, Res. Results Pharmacol., 7(3), 63 – 71 (2021).
I. L. Nikitina, G. G. Gaisina, E. F. Galimova, et al., CNS Neurol. Disord.: Drug Targets, 20(10), 982 – 995 (2021).
O. A. Ivanova, I. L. Nikitina, E. K. Alekhin, et al., Kazan. Med. Zh., 93(1), 108 – 112 (2012).
E. E. Klen, N. N. Makarova, F. A. Khaliullin, et al., Bashk. Khim. Zh., 15(4), 112 – 114 (2008).
F. A. Khaliullin, I. L. Nikitina, E. E. Klen, et al., Khim.-farm. Zh., 55(2), 13 – 19 (2021); Pharm. Chem. J., 55(2), 123 – 129 (2021).
E. E. Klen, I. L. Nikitina, O. A. Ivanova, et al., Vopr. Biol., Med. Farm. Khim., 20(12), 4 – 9 (2017).
S. R. Khan, R. T. Berendt, C. D. Ellison, et al., Profiles Drug Subst. Excipients Relat. Methodol., 41, 1 – 30 (2016).
M. T. Jones, M. T. Strassnig, and P. D. Harvey, Expert Opin. Emerging Drugs, 25, 189 – 200 (2020).
S. Lesniak, W. J. Kinart, and J. Lewkowski, in: Comprehensive Heterocyclic Chemistry III, A. R. Katritzky, C. A. Ramsden, E. F. V. Scriven, and R. J. K. Taylor (eds.), Oxford (2008), pp. 389 – 428.
J. Contreras and S. Madariaga, Bol. Soc. Chil. Quim., No. 3, 469 – 478 (2000).
D. C. Dittmer, B. H. Patwardhan, and J. T. Bartholomew, Org. Magn. Reson., 18(2), 82 – 86 (1982).
E. Pretsch, P. Buhlmann, and C. Affolter, Structure Determination of Organic Compounds, Springer, Berlin, New York-2000).
E. E. Klen, N. N. Makarova, and F. A. Khaliullin, Chem. Heterocycl. Compd., 48(10), 1473 – 1476 (2013).
T. Alpers, T. W. T. Muesmann, O. Temme, et al., Eur. J. Org. Chem., 2018(31), 4331 – 4337 (2018).
E. E. Klen, F. A. Khaliullin, N. N. Makarova, et al., Zh. Org. Khim., 44, 1729 – 1731 (2008).
S. A. Laufer, D. R. J. Hauser, and A. J. Liedtke, Synthesis, 2008(02), 253 – 266 (2008).
L. Steru, Psychopharmacology, 85(3), 367 – 370 (1985).
E. V. Shchetinin, V. A. Baturin, E. B. Arushanyan, et al., Zh. Vyssh. Nervn. Deyat., 39, 958 – 964 (1989).
A. V. Val’dman and V. P. Poshivalov, Pharmacological Regulation of Intraspecies Behavior [in Russian], Meditsina, Leningrad (1984).
European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, ETS No. 123, Strasbourg (1986).
Decision No. 81 of the Council of the Eurasian Economic Commission of Nov. 3, 2016, On Approval of Good Laboratory Practice Rules of the Eurasian Economic Union in the Field of Drug Circulation, (2020).
Certificate of State Registration of Computer Program No. 2008610170-Russia, (2008).
W. B. Deichmann and T. J. LeBlanc, J. Ind. Hyg. Toxicol., 25, 415 – 417 (1943).
S. White, Basic & Clinical Biostatistics: Fifth Edition, McGraw-Hill Education, (2019).
A. Daina, O. Michielin, and V. Zoete, Sci. Rep., 7, 42717 (2017).
A. A. Lagunin, A. V. Zakharov, D. S. Filimonov, et al., Mol. Inf., 30(2 – 3), 241 – 250 (2011).
GOST 12.1.007–76, System of Labor Safety Standards-SLSS). Hazardous Substances. Classification and General Safety Requirements-with Amendments (Nos. 1 and 2) of March 10, 1976 (2022).
I. V. Berezovskaya, Khim.-farm. Zh., 37, No. 3, 32 – 34 (2003); Pharm. Chem. J., 37(3), 139 – 141 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 12, pp. 27 – 34, December, 2022.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Khaliullin, F.A., Klen, E.E., Nikitina, I.L. et al. Synthesis and Antidepressant Activity of Thietane-Containing 4-(2-oxo-2-phenylethyl)-1H-1,2,4-triazol-4-ium Bromides. Pharm Chem J 56, 1596–1603 (2023). https://doi.org/10.1007/s11094-023-02832-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02832-1